DIABETIC KETOACIDOSIS ASSOCIATED WITH EMPAGLIFLOZIN THERAPY : MECHANISMS, RISC FACTORS AND CLINICAL IMPLICATIONS. (2025). International Journal of Artificial Intelligence, 5(09), 221-223. https://www.academicpublishers.org/journals/index.php/ijai/article/view/6299